In Russia, the maximum indicators for the number of new cases of COVID-19 and the number of deaths per day have been updated - 32 196 and 999, respectively.

Previous anti-records were recorded the day before - 31,299 and 985.

During the entire observation period, the diagnosis of COVID-19 in Russia was confirmed in 7,925,176 people, of which 6,950,024 fully recovered.

The number of deaths reached 221 313.

Meanwhile, the Russian Ministry of Health has released a new, 13th version of temporary guidelines for the prevention, diagnosis and treatment of a new coronavirus infection.

The new document updated the sections on drug therapy.

We are talking, in particular, about the use of monoclonal antibodies in the therapy of COVID-19.

“Their use in patients with risk factors for severe course will neutralize the virus at an early stage and stop the unfavorable development of the disease.

Also, outpatient drug therapy schemes have been improved, allowing early prevention of excessive inflammatory response, ”the press release says.

There are no grounds for introducing a federal lockdown in Russia, despite the serious situation with COVID-19.

This was stated in an interview with RT by the speaker of the Federation Council Valentina Matvienko.

“The situation is not easy.

But there is no reason to introduce a federal lockdown.

And I want to calm our business, and enterprises, and people.

It is inappropriate to do this, because it will have extremely negative consequences for the people and for the country as a whole, ”Matvienko said.

Denis Protsenko, the chief physician of the Moscow hospital No. 40 in Kommunarka, on his Telegram channel also noted the alarming epidemiological situation in the country.

“The situation, if not critical, is close to this,” wrote Protsenko.

In this regard, he urged Russians to be more actively vaccinated against COVID-19, not to shy away from early diagnosis, observe a mask regime, and, turning to doctors, stressed that they should frankly tell patients about the situation and strengthen explanatory work.

“Guys, however, the coronavirus is not a joke or a fiction, it’s surprising that in the second year of the pandemic we still need to convince people of this,” said the head physician of the hospital in Kommunarka.

"Sputnik V"

National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F.

Gamalei has applied for permanent registration of his Sputnik V vaccine.

RIA Novosti was informed about this by the director of the center, Alexander Gintsburg.

He emphasized that post-registration studies of the drug were completed.

“Yes, they have been completed, the documents have been submitted, and they are now being considered,” Gunzburg said.

As a reminder, Sputnik V became the first registered vaccine against COVID-19.

This happened on August 11, 2020.

The drug received approval from the Ministry of Health on condition that post-registration clinical trials, which began in September of that year, were carried out.

In the course of an interim analysis of studies in the Russian Federation, the effectiveness of the vaccine was 92%, while it was indicated that it fully protects against severe and fatal cases.

In December, the Ministry of Health authorized the use of Sputnik V for mass vaccination of people over 60 years of age.

In July 2021, a clinical trial of a vaccine for adolescents aged 12 to 17 was launched.

In August, according to a study conducted in Argentina, RDIF reported that protection against COVID-19 is gradually increasing within six months after being vaccinated with Sputnik V.

In September, the center of Gamaleya emphasized that no deaths after vaccinations with the drug were detected.

It was also reported that the effectiveness of "Sputnik V" against the world's most common strain of coronavirus "delta" is from 83% to 94% (depending on the method of calculation).

As of October 15, more than 62 million complete vaccine kits have been released into civilian circulation.

Meanwhile, the process of approval of "Sputnik V" at the international level continues.

According to the latest information, the details of the visit of representatives of the European Medicines Agency (EMA) for the certification of the Russian vaccine are being coordinated.

In addition, the World Health Organization may register a domestic drug for emergency use by the end of the year.

To date, Sputnik V has been approved in 70 countries with a total population of 4 billion people, which is more than 50% of the world's population.

In terms of the number of approvals received by state regulators, the drug ranks second in the world.

This week, President Vladimir Putin stressed that he escaped the coronavirus outbreak in his environment last month thanks to the Sputnik V vaccine.

The head of state was in September on a two-week self-isolation.

Express testing in Moscow

Since the beginning of work in Moscow, 20 points for those wishing to undergo express testing for COVID-19 for free, 13 thousand people have already taken advantage of this opportunity.

This was announced by the vice-mayor of the capital Anastasia Rakova.

“Over the past day alone, more than 3 thousand express tests were carried out, of which 95% were negative, and only about 150 were positive. In just four days, 13 thousand people underwent express screening, of which more than 12 thousand received a negative result and only about 650 - a positive one. Upon receipt of a positive express test, we immediately carry out PCR testing on the spot to confirm the diagnosis. Now PCR is ready in 560 people, of whom 78% - in 440 citizens - have already confirmed the diagnosis. Thus, we were able to identify the disease at an early stage and prevent further spread of the infection, ”she said.

From October 11, in 10 public places and 10 MFCs in the capital, free rapid testing points for antigen to coronavirus infection have been launched.

Later, a project was launched on free express testing for COVID-19 in 10 schools in the capital - students will take the test every two weeks.